HOTH THERAPEUTICS INC (HOTH) Fundamental Analysis & Valuation

NASDAQ:HOTH • US44148G2049

0.9968 USD
-0.02 (-2.27%)
At close: Mar 3, 2026
0.9126 USD
-0.08 (-8.45%)
Pre-Market: 3/4/2026, 8:59:04 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This HOTH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Taking everything into account, HOTH scores 2 out of 10 in our fundamental rating. HOTH was compared to 193 industry peers in the Pharmaceuticals industry. The financial health of HOTH is average, but there are quite some concerns on its profitability. HOTH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. HOTH Profitability Analysis

1.1 Basic Checks

  • In the past year HOTH has reported negative net income.
  • In the past year HOTH has reported a negative cash flow from operations.
  • HOTH had negative earnings in each of the past 5 years.
  • In the past 5 years HOTH always reported negative operating cash flow.
HOTH Yearly Net Income VS EBIT VS OCF VS FCFHOTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

  • HOTH has a Return On Assets of -131.58%. This is amonst the worse of the industry: HOTH underperforms 82.38% of its industry peers.
  • HOTH's Return On Equity of -147.77% is on the low side compared to the rest of the industry. HOTH is outperformed by 69.43% of its industry peers.
Industry RankSector Rank
ROA -131.58%
ROE -147.77%
ROIC N/A
ROA(3y)-118.92%
ROA(5y)-124.88%
ROE(3y)-143.37%
ROE(5y)-145.96%
ROIC(3y)N/A
ROIC(5y)N/A
HOTH Yearly ROA, ROE, ROICHOTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for HOTH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HOTH Yearly Profit, Operating, Gross MarginsHOTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. HOTH Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for HOTH has been increased compared to 1 year ago.
  • The number of shares outstanding for HOTH has been increased compared to 5 years ago.
  • There is no outstanding debt for HOTH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HOTH Yearly Shares OutstandingHOTH Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
HOTH Yearly Total Debt VS Total AssetsHOTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -4.78, we must say that HOTH is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -4.78, HOTH is not doing good in the industry: 60.10% of the companies in the same industry are doing better.
  • There is no outstanding debt for HOTH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.78
ROIC/WACCN/A
WACCN/A
HOTH Yearly LT Debt VS Equity VS FCFHOTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

  • A Current Ratio of 8.81 indicates that HOTH has no problem at all paying its short term obligations.
  • HOTH's Current ratio of 8.81 is fine compared to the rest of the industry. HOTH outperforms 77.20% of its industry peers.
  • A Quick Ratio of 8.81 indicates that HOTH has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 8.81, HOTH is doing good in the industry, outperforming 77.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.81
Quick Ratio 8.81
HOTH Yearly Current Assets VS Current LiabilitesHOTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. HOTH Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.30% over the past year.
EPS 1Y (TTM)20.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.23%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, HOTH will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.53% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y60.12%
EPS Next 2Y24.4%
EPS Next 3Y13.53%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HOTH Yearly Revenue VS EstimatesHOTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 100M 200M 300M 400M
HOTH Yearly EPS VS EstimatesHOTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. HOTH Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HOTH. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HOTH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HOTH Price Earnings VS Forward Price EarningsHOTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HOTH Per share dataHOTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • HOTH's earnings are expected to grow with 13.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.4%
EPS Next 3Y13.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HOTH Dividend Analysis

5.1 Amount

  • HOTH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HOTH Fundamentals: All Metrics, Ratios and Statistics

HOTH THERAPEUTICS INC

NASDAQ:HOTH (3/3/2026, 8:17:18 PM)

Premarket: 0.9126 -0.08 (-8.45%)

0.9968

-0.02 (-2.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12
Earnings (Next)03-26
Inst Owners8.61%
Inst Owner Change-26.07%
Ins Owners3.57%
Ins Owner Change0%
Market Cap15.46M
Revenue(TTM)N/A
Net Income(TTM)-12.16M
Analysts82.86
Price Target5.1 (411.64%)
Short Float %7.31%
Short Ratio2.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-106.58%
Min EPS beat(2)-194.12%
Max EPS beat(2)-19.05%
EPS beat(4)1
Avg EPS beat(4)-49.94%
Min EPS beat(4)-194.12%
Max EPS beat(4)15.21%
EPS beat(8)4
Avg EPS beat(8)-13.78%
EPS beat(12)7
Avg EPS beat(12)-5.15%
EPS beat(16)10
Avg EPS beat(16)-1.59%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.11%
PT rev (3m)25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.88
P/tB 1.88
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.6
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.62
OCFYN/A
SpS0
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -131.58%
ROE -147.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-118.92%
ROA(5y)-124.88%
ROE(3y)-143.37%
ROE(5y)-145.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.81
Quick Ratio 8.81
Altman-Z -4.78
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.23%
EPS Next Y60.12%
EPS Next 2Y24.4%
EPS Next 3Y13.53%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-61.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.09%
OCF growth 3YN/A
OCF growth 5YN/A

HOTH THERAPEUTICS INC / HOTH FAQ

What is the fundamental rating for HOTH stock?

ChartMill assigns a fundamental rating of 2 / 10 to HOTH.


What is the valuation status of HOTH THERAPEUTICS INC (HOTH) stock?

ChartMill assigns a valuation rating of 0 / 10 to HOTH THERAPEUTICS INC (HOTH). This can be considered as Overvalued.


Can you provide the profitability details for HOTH THERAPEUTICS INC?

HOTH THERAPEUTICS INC (HOTH) has a profitability rating of 0 / 10.


What is the financial health of HOTH THERAPEUTICS INC (HOTH) stock?

The financial health rating of HOTH THERAPEUTICS INC (HOTH) is 7 / 10.